Arkema (AKE) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Jul, 2026Executive summary
2024 sales reached €9.54 billion, with EBITDA up 2.1% to €1.53 billion and a 16.1% margin, reflecting resilience amid weak global demand and regional disparities.
Specialty Materials accounted for 92% of sales, driving volume growth, especially in Asia, while Europe declined and North America was stable.
Growth was supported by Adhesives and High Performance Polymers, major acquisitions, and a balanced global footprint.
Major acquisitions included Dow's laminating adhesives and PI Advanced Materials, supporting flexible packaging and electronics.
Strengthened CSR targets and continued innovation in sustainable materials.
Financial highlights
Group sales stable year-on-year at €9.54 billion; volumes up 2.4%, prices down 3.0%.
EBITDA rose 2.1% to €1.53 billion (16.1% margin); adjusted net income was €616 million (€8.23/share).
Recurring cash flow was €419 million; free cash flow totaled €358 million, including €61 million non-recurring outflows.
Net debt stood at €3.24 billion, with a net debt/EBITDA ratio of 2.1x.
Proposed dividend of €3.60 per share, up 2.9%, with a 44% payout ratio.
Outlook and guidance
2025 EBITDA guidance set between €1.53 billion and €1.67 billion, with €100 million incremental EBITDA from major Specialty Materials projects.
Recurring cash flow targeted at €600 million in 2025, driven by lower CapEx and working capital discipline.
Q1 2025 EBITDA expected slightly below prior year due to soft demand, especially in Europe and the U.S.
Major projects to contribute around €100 million additional EBITDA in 2025.
Intermediate segment EBITDA expected to decrease by €30 million due to refrigerant quota reductions.
Latest events from Arkema
- EBITDA reached €1,251m with strong cash flow and resilience in key growth markets.AKE
Q4 20259 Jul 2026 - Sales rose 1.7% with resilient specialty materials, but profits fell; H2 improvement expected.AKE
Q1 20259 Jul 2026 - Q2 2024 EBITDA rose 8.2% on 3.8% sales growth; guidance raised to €1.53–1.63bn.AKE
Q2 202430 Jun 2026 - Resilient 2025 results, strategic investments, and strong governance marked the AGM.AKE
AGM 202621 May 2026 - Stable volumes and Specialty growth offset lower sales; 2026 EBITDA growth targeted.AKE
Q1 20266 May 2026 - Q3 2024 EBITDA rose 5.4% to €407 million, margin at 17.0%, amid weak demand and tight debt control.AKE
Q3 202416 Jan 2026 - Ambitious growth, innovation, and sustainability drive strong specialty materials performance.AKE
BNPP Exane CEO Conference Presentation13 Jan 2026 - Q3 2024 saw higher sales and EBITDA, with strong specialty materials growth and sustainability focus.AKE
BOFA European Materials Conference 2024 Presentation13 Jan 2026 - Solid Q2 growth and sustainability focus drive higher 2024 EBITDA outlook of €1.53–1.63bn.AKE
Investor presentation13 Jan 2026